Andrea Wang-Gillam, MD, PhD

Andrea Wang-Gillam, MD, PhD, assistant professor, Department of Medicine, Oncology Division, Washington University School of Medicine in St. Louis, discusses a trial looking at PF-04136309, an investigational chemokine receptor antagonist, in combination with FOLFIRINOX for the treatment of locally advanced pancreatic cancer.

Back to the Gastrointestinal Cancers Symposium conference page

Articles

Andrea Wang-Gillam, MD, PhD, discusses a trial looking at PF-04136309, an investigational chemokine receptor antagonist, in combination with FOLFIRINOX for the treatment of locally advanced pancreatic cancer.

Andrea Wang-Gillam, MD, PhD | Authors

Articles

Treatment With a Monocyte-Targeting Agent for Pancreatic Cancer